March 08, 2021
2 min watch
Save
VIDEO: Meeting to address undertreatment of CVD in patients with psoriatic disease
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania, discusses an upcoming program from the National Heart, Lung, and Blood Institute.
The meeting will discuss the undertreatment of traditional cardiovascular risk factors in people with psoriatic disease, focusing in particular on the use of statins.
The meeting will be held April 9. Register for this free event by clicking here.